Tonix Pharmaceuticals Announces the Isolation and Characterization of the (S)-Isomer of Tianeptine, TNX-4300, Now under Development for Psychiatric and Neurodegenerative Diseases - Marketscreener.com
Submitted by Anonymous (not verified) on Wed, 05/24/2023 - 12:50
